EP 3585420 A2 20200101 - PEPTIDES AND METHODS OF TREATING DYSTROPHY-RELATED DISORDERS USING THE SAME
Title (en)
PEPTIDES AND METHODS OF TREATING DYSTROPHY-RELATED DISORDERS USING THE SAME
Title (de)
PEPTIDE UND VERFAHREN ZUR BEHANDLUNG VON DYSTROPHIEBEDINGTEN ERKRANKUNGEN DAMIT
Title (fr)
PEPTIDES ET MÉTHODES DE TRAITEMENT D'AFFECTIONS LIÉES À LA DYSTROPHIE LES UTILISANT
Publication
Application
Priority
- US 201762462292 P 20170222
- US 2018019279 W 20180222
Abstract (en)
[origin: WO2018156801A2] The disclosure relates to a pharmaceutical composition comprising any one or combination of PIF peptides or analogs or pharmaceutically acceptable salts thereof. Methods of treating a dystrophy-related disorder using the one or a combination of PIF peptide or analogs thereof or pharmaceutically acceptable salts thereof are also disclosed.
IPC 8 full level
A61K 38/19 (2006.01); A61K 38/04 (2006.01); A61K 38/08 (2019.01); A61K 38/10 (2006.01); A61K 38/17 (2006.01)
CPC (source: EP)
A61K 38/10 (2013.01); A61K 45/06 (2013.01); A61P 9/00 (2017.12); A61P 11/00 (2017.12); A61P 13/12 (2017.12); A61P 21/00 (2017.12)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2018156801 A2 20180830; WO 2018156801 A3 20190221; AU 2018225163 A1 20190919; CA 3054366 A1 20180830; CN 110869044 A 20200306; EP 3585420 A2 20200101; EP 3585420 A4 20210407; EP 4066850 A2 20221005; EP 4066850 A3 20221123; IL 268844 A 20191031
DOCDB simple family (application)
US 2018019279 W 20180222; AU 2018225163 A 20180222; CA 3054366 A 20180222; CN 201880026431 A 20180222; EP 18756867 A 20180222; EP 22150813 A 20180222; IL 26884419 A 20190822